Commodore Capital LP
CIK: 0001831942Latest portfolio: $1.5B · Q4 2025
Holdings
33
Total Value
$1.5B
New Positions
6
Closed Positions
9
Top Holdings
View All 33 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | RLAYRELAY THERAPEUTICS INC | 17,000,000 | $143.8M | 9.57% | — | |
| 2 | ALKSALKERMES PLC | 3,550,000 | $99.3M | 6.61% | +453K | |
| 3 | TYRATYRA BIOSCIENCES INC | 3,375,000 | $88.7M | 5.91% | — | |
| 4 | XENEXENON PHARMACEUTICALS INC | 1,800,000 | $80.7M | 5.37% | -900,000 | |
| 5 | SYRESPYRE THERAPEUTICS INC | 2,388,245 | $78.2M | 5.21% | +400K | |
| 6 | COGTCOGENT BIOSCIENCES INC | 2,196,845 | $78.0M | 5.19% | -5,053,155 | |
| 7 | ELVNENLIVEN THERAPEUTICS INC | 4,692,809 | $72.3M | 4.81% | — | |
| 8 | TCE2CELLDEX THERAPEUTICS INC NEW | 2,565,000 | $69.7M | 4.64% | -463,335 | |
| 9 | AMLXAMYLYX PHARMACEUTICALS INC | 5,650,000 | $68.3M | 4.54% | +1.6M | |
| 10 | TERNTERNS PHARMACEUTICALS INC | 1,475,000 | $59.6M | 3.97% | -4,225,000 | |
| 11 | KYMRKYMERA THERAPEUTICS INC | 750,000 | $58.4M | 3.88% | — | |
| 12 | SLNOSOLENO THERAPEUTICS INC | 1,200,000 | $55.6M | 3.70% | -150,000 | |
| 13 | NUVLNUVALENT INC | 550,000 | $55.3M | 3.68% | -850,000 | |
| 14 | ORKAORUKA THERAPEUTICS INC | 1,753,054 | $53.1M | 3.54% | — | |
| 15 | PHVSPHARVARIS N V | 1,889,445 | $52.4M | 3.49% | -529,031 | |
| 16 | NRIXNURIX THERAPEUTICS INC | 2,275,000 | $43.2M | 2.87% | -1,505,055 | |
| 17 | PTGXPROTAGONIST THERAPEUTICS INC | 450,000 | $39.3M | 2.62% | -575,000 | |
| 18 | ASMBASSEMBLY BIOSCIENCES INC | 1,000,000 | $34.0M | 2.26% | — | |
| 19 | LBRXLB PHARMACEUTICALS INC | 1,500,000 | $33.4M | 2.22% | — | |
| 20 | CTMXCYTOMX THERAPEUTICS INC | 7,692,300 | $32.8M | 2.18% | — | |
| 21 | ANROALTO NEUROSCIENCE INC | 1,823,196 | $32.5M | 2.16% | NEW | |
| 22 | PALIPALISADE BIO INC | 11,445,000 | $26.9M | 1.79% | NEW | |
| 23 | BRD1EURMIND MEDICINE MINDMED INC | 2,000,000 | $26.8M | 1.78% | -1,225,000 | |
| 24 | CNTACENTESSA PHARMACEUTICALS PLC | 1,000,000 | $25.0M | 1.66% | -1,850,000 | |
| 25 | PEPGPEPGEN INC | 3,400,000 | $22.1M | 1.47% | +1.0M |
Quarterly Changes
Increased Positions
Sector Breakdown
Healthcare0.0% ($1.4382099329887288e+141T)
Unknown0.0% ($7.0T)
Filing History
| Quarter | Filing Date | Portfolio Value | Holdings |
|---|---|---|---|
| Q4 2025 | Feb 17, 2026 | $1.5B | 33 |
| Q3 2025 | Nov 14, 2025 | $2.0T | 37 |
| Q2 2025 | Aug 14, 2025 | $1.4T | 33 |
| Q1 2025 | May 15, 2025 | $1.4T | 31 |
| Q4 2024 | Feb 14, 2025 | $1.4T | 31 |
| Q3 2024 | Nov 14, 2024 | $1600.3T | 36 |
| Q2 2024 | Aug 14, 2024 | $1465.0T | 35 |
| Q1 2024 | May 15, 2024 | $1495.5T | 39 |
| Q4 2023 | Feb 14, 2024 | $1155.8T | 32 |
| Q3 2023 | Nov 14, 2023 | $855.5T | 30 |
| Q2 2023 | Aug 14, 2023 | $889.8T | 26 |
| Q1 2023 | May 15, 2023 | $656.8T | 32 |
| Q4 2022 | Feb 14, 2023 | $663.5B | 35 |
| Q3 2022 | Nov 14, 2022 | $621.9B | 30 |
| Q2 2022 | Aug 15, 2022 | $473.0B | 24 |
| Q1 2022 | May 16, 2022 | $447.7B | 27 |
| Q4 2021 | Feb 14, 2022 | $431.8B | 25 |
| Q3 2021 | Nov 15, 2021 | $379.3B | 29 |
| Q2 2021 | Aug 16, 2021 | $290.3B | 29 |
| Q1 2021 | May 17, 2021 | $254.0B | 31 |
| Q4 2020 | Feb 16, 2021 | $183.9B | 28 |
Fund Information
Commodore Capital LP is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $1.5B across 33 holdings. The largest position is RELAY THERAPEUTICS INC (RLAY), representing 9.6% of the portfolio. Compared to the previous quarter, the fund opened 6 new positions and closed 10 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.